Anti-idiotype immunization of cancer patients: modulation of the immune response.

Thirty patients with advanced colorectal carcinoma (CRC) were treated with alum-precipitated polyclonal goat anti-idiotypic antibodies (Ab2) to monoclonal anti-CRC antibody CO17-1A (Ab1) in doses between 0.5 and 4 mg per injection. All patients developed anti-anti-idiotypic antibodies (Ab3) with bin...

Celý popis

Podrobná bibliografie

Vydáno v:	Proc Natl Acad Sci U S A
Hlavní autoři:	Herlyn, D, Wettendorff, M, Schmoll, E, Iliopoulos, D, Schedel, I, Dreikhausen, U, Raab, R, Ross, A H, Jaksche, H, Scriba, M
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	National Academy of Sciences 1987
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC299476/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3500471/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.84.22.8055
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!